TRV-7019
TRV-7019 is a BBB-penetrable radioligand for brain imaging that target butyrylcholinesterase. TRV-7019 can be used for the diagnosis of an amyloid disease, multiple sclerosis, a brain tumor, or butyrylcholinesterase activity[1].
Product Specifications
CAS Number
2598164-15-7
UNSPSC
12352005
Target
Cholinesterase (ChE)
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/trv-7019.html
Purity
99.64
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=NC(OC)=CC=C1)OCC2=CC=C(I)C=C2
Molecular Formula
C14H12INO3
Molecular Weight
369.15
References & Citations
[1]Sultan Darvesh, et al. Butyrylcholinesterase compounds and use in diseases of the nervous system. Patent WO2021026429A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BChE
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
W/W030/NL358/RFLBD-400X600-1 Electrical & Equipment Safety Signs (No Adhesive)
INPP5J Antibody - N-terminal region : FITC (ARP42408_P050-FITC)